期刊文献+

围生期心肌病发病相关因素的研究 被引量:6

Study of factors related to peripartum cardiomyopathy
原文传递
导出
摘要 目的 探讨围生期心肌病(PPCM)发病的相关因素.方法 时82例PPCM患者进行流行病学调查,检查心脏彩超,测定肌钙蛋白I(cTNI)、高敏C-反应蛋白(hs-CRP)、N末端B型利钠肽(NT-proBNP)等指标,并随机对其中52例患者进行了平均6个月的随访.对照组选用同期住院的正常分娩患者.结果 PPCM患者与对照组相比,年龄较大[分别为(29.5±6.4)岁和(25.2±5.8)岁,P〈0.01],血压较高(分别为146.9/98.8 mm Hg和130.2/80.1 mm Hg,P〈0.01),剖宫产比例较高(分别为65.9%和51.0%,P〈0.05),合并感染率明显升高(分别为75.6%和10.0%,P〈0.01),实验室检查白细胞(分别为11.0×109/L和8.8×109/L,P〈0.01)、cTNI(分男q为0.17μg/L和0.06μg/L,P〈0.01)、hs-CRP(分别为2 8.2ms/L和6.2 mg/L,P〈0.01)、NT-proBNP(分别为650.1 ng/L和110.5 ns/L,P〈0.01)明显升高,hs-CRP和NT-proBNP呈正相关(r=0.67,P〈0.01).经过平均6个月的治疗,平均射血分数由32.2%提高至50.6%,NT-proBNP明显下降(治疗前、后分别为650.1 ng/L和225.6 ng/L,P〈0.01),NT-proBNP下降的独立影响因素为舒张压下降(P〈0.05)、左心室舒张末径缩小(P〈0.05)和hs-CRP下降(P〈0.05).结论 炎症反应在围生期心肌病发病中起了重要的作用. Objective To explore the risk factors of peripartum cardiomyopathy (PPCM). Methods A total of 82 PPCM and 100 normal delivery females were randomly recruited in the current study. Echocardiographic, cTNI,high sensitive C-reaction protein(hs-CRP) ,NT-proBNP were measured. Fifty-two patients were followed up for a mean of 6 months. Results The PPCM patients (29. 5 ± 6. 4) yrs were older than the controls (25. 2 ± 5. 8) yrs (P〈0.01) . Compared to the controls, the PPCM patients showed higher blood pressure (146.9/98. 8 mm Hg v. s. 130. 2/80. 1 mm Hg, P 〈 0. 01) , higher proportion of cesarean section (65. 9% v. s. 51. 0% , P 〈 0. 05) and complicated infection(75. 6% v. s. 10. 0% ,P 〈0. 01). The level of leucocyte(11.0 × 109/L) ,cTNI(0. 17 μg/L), hs-CRP(28. 2 mg/L)and NT-proBNP(650. 1 ng/L) were significantly higher in the PPCM patients compared with control(8. 8 × 109/L,0. 06μg/L,6. 2 mg/L and 110. 5 ng/L,P 〈0. 01). Hs-CRP was positively related with NT-proBNP(r = 0. 67, P 〈 0. 01). After average of 6 months of treatment, left ventricular ejection fraction enhanced from 32. 2% to 50. 6%. NT-proBNP significantly declined from 650. 1 ng/L to 225.6 ng/L(P 〈0. 01). Multiple linear regression analysis showed that diastolic pressure (P 〈 0. 05), LVED (P 〈 0. 05) and hs-CRP (P 〈 0. 05) were the independent predictors for declined NT-proBNP. Conclusions Inflammatory plays an important role in the development of peripartum cardiomyopathy.
出处 《中国综合临床》 2010年第6期640-642,共3页 Clinical Medicine of China
关键词 围生期心肌病 炎症 Peripartum cardiomyopathy Inflammatory
  • 相关文献

参考文献5

  • 1Abboud J,Murad Y,Chen-Scarabelli C,et aL Peripartum cardiomyopathy:a comprehensive review[J].Int J Cardiol,2007,118(3):295-303. 被引量:1
  • 2Fett JD.Understanding peripartum cardiomyopathy,2008[J].Int J Cardiol,2008,130(1):l-2. 被引量:1
  • 3心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:547
  • 4Sliwa K,Skudicky D,Bergemann A,et aL Peripartum cardiomyopathy:analysis of clinical outcome,left ventricular function,plasma levels of cytokines and Fas/APO-1[J].J Am Coll CardioL 2000,35 (3):701-705. 被引量:1
  • 5Ktthl U,Pauschinger M,Seeberg B,et al.Viral persistence in the myocardium is associated with progressive cardiac dysfunction[J].Circulation,2005,112(13):1965-1970. 被引量:1

二级参考文献68

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:59
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842. 被引量:1
  • 5Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816. 被引量:1
  • 6Elliott PM,Mckenna WJ.Natural history of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/11502&type=A&selectedTitle=4~58. 被引量:1
  • 7Cooper LT.Definition and classification of the cardiomyopathies.[EB/OL][2006-8-2].http://www.utdol.com.beckerproxy.wustl.edu/applica.../6085&type=A&selectedTitle=2~5. 被引量:1
  • 8McKenna WJ.Genetics of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/9673&type=A&selectedTitle=3~58. 被引量:1
  • 9Poliac LC,Barron ME,Maron BJ.Hypertrophic cardiomyopathy.Anesthesiology,2006,104(1):183-192. 被引量:1
  • 10Maron BJ,Seidman JG,Seidman CE.Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.J Am Coll Cardiol,2004,44(11):2125-2132. 被引量:1

共引文献546

同被引文献56

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部